Search - tctmd.com

Displaying 541 - 560 of 874

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

Presenter: George D. Dangas

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Presenter: James B. Hermiller Jr

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Presenter: Hüseyin Ince

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Presenter: Anita Asgar

June 21, 2018

Presentation EuroPCR 2018

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Presenter: Lars Sondergaard

May 25, 2018

Presentation

Pulmonary Hypertension (PH) in Pts With Severe Aortic Stenosis: Prognostic Impact After TAVR

April 20, 2018

Presentation ECHO 2018

Low Gradient, Severe(?) Aortic Stenosis

Presenter: Philippe Pibarot

April 19, 2018

Presentation ECHO 2018

The Role of Echo in the Management of Asymptomatic VHD

Presenter: Philippe Pibarot

April 18, 2018

Presentation ECHO 2018

Stress Echo cases

Presenter: Stephen H. Little

April 18, 2018

Presentation ECHO 2018

Aortic Stenosis: Basic and Advanced Echo Assessment New Guideline

Presenter: Jae K. Oh

April 18, 2018

Presentation CRT 2018

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Presenter: Ron Waksman

March 04, 2018

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Advertisement

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

UK All-Comers

Evolut R Low-Risk

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Partner 3 Low-Risk

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Pharmacotherapy Considerations Trials and Practical Clinical Recommendations

A Growing Conundrum: Coronary Access After TAVR Technical Tips and Tricks

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

The Role of MitraClip After TAVR: A Case-Based Tutorial (Who, When, and How)

Clinical Decision-Mmaking in AS and MR Patients: Choosing the Best Patients for Multivalve Interventions

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Pulmonary Hypertension (PH) in Pts With Severe Aortic Stenosis: Prognostic Impact After TAVR

Low Gradient, Severe(?) Aortic Stenosis

The Role of Echo in the Management of Asymptomatic VHD

Stress Echo cases

Aortic Stenosis: Basic and Advanced Echo Assessment New Guideline

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content